PulsePoint and CMI Media Group Introduce First Agency Activation of HCP2DTC Influence

In July 2026, PulsePoint, a prominent healthcare marketing company, unveiled the first agency activation of HCP2DTC Influence. This is its proprietary technology that provides connectivity for healthcare professionals to direct-to-consumer activation at a commercial scale. CMI Agency is its first agency collaborator that is implementing HCP2DTC Influence in a prominent oncology firm to bring doctor and patient marketing closer.

Pharmaceutical marketing teams acknowledge that knowing the needs of medical professionals is one of the most important things to boost the sales of their products. They have conventionally been limited to HCP campaigns. HCP2DTC influence helps to go beyond HCP campaigns and enables pharmaceutical companies to utilize their healthcare professional technique to let the patient know. This helps to integrate HCP and DTC marketing, which has not been conventionally possible.

According to Andrew Stark, the Chief Commercial Officer of PulsePoint, the distance in HCP and DTC influence has been a major concern that has been overlooked by the pharmaceutical media. He said that CMI Media Group quickly acknowledged this issue and emerged as the first agency to resolve it by activating the HCP2DTC influence. This is an important breakthrough for the company as their strategy is to further expand their solution to more agencies and pharmaceutical collaborators.

According to Justin Fried, the Group President, Media, at CMI Media Group, the strategic harmony between DTC and HCP influence is important to ensure marketing success and enhancement in patient outcomes. He said that the company is delighted to be the first agency to bring this solution to the market and provide it to its customers.

Impact on the Healthcare Industry

According to Precedence Research, the launch of the HCP2DTC influence is expected to positively impact the healthcare industry as it bridges the gap between HCP and DTC marketing, allowing them to better cater to the needs of patients. They can utilize the insights from the qualified medical professionals to design relevant healthcare products and then provide them to the patients. The doctors can also recommend those specific brands to their patients as they trust the brand because their product has been developed after taking guidance from the doctor himself/herself.

Impact on the Healthcare Business Intelligence Market

The global healthcare business intelligence market size is accounted at USD 11.41 billion in 2025 and predicted to increase from USD 12.95 billion in 2026 to approximately USD 39.64 billion by 2035, representing a CAGR of 13.26% from 2025 to 2035.

According to Precedence Research, the healthcare business intelligence market is expected to be positively impacted by the launch of the HCP2DTC influence owing to the fact that it will help healthcare marketing companies make better strategies to bring their product to the consumers. It will help them benefit from the insights and guidance from the medical professionals as well as make their product visible to the patients directly using an integrated platform. This way, they can connect with doctors as well as patients, widening their reach and building a reputation among patients as well as the physician ecosystem.

Impact on the Healthcare Distribution Market

The global healthcare distribution market size was valued at USD 1.19 trillion in 2025 and is predicted to increase from USD 1.28 trillion in 2026 to approximately USD 2.34 trillion by 2035, expanding at a CAGR of 7.00% from 2026 to 2035.

According to Precedence Research, the launch of the HCP2DTC influence is expected to benefit the healthcare distribution market as it allows doctors and pharmaceutical companies to communicate with each other while also being aware of the needs of the patients. This helps them share technical knowledge with each other and build healthcare products, keeping in mind the requirements of the patients.

The patients also get to ask their queries and get guidance from pharmaceutical brands as well as medical professionals about their treatment and about the healthcare products, as both institutions have fairly good knowledge due to their communication. This launch will be a big relief for patients with chronic diseases who live in remote regions and have to take drugs at specific intervals of time, be it daily or weekly. They would not need to travel to a city each time they need medical assistance and can seek guidance from the local pharma retail suppliers.

About PulsePoint

PulsePoint is a healthcare technology solutions provider and assists its clients in delivering medical services better. The company gathers deep insights from patients that are usually missed by medical and pharmaceutical organizations and real-world health data to provide excellent and beneficial healthcare solutions for the patient. PulsePoint provides comprehensive marketing applications that are developed after analyzing a diverse array of real-world data, advanced technologies, and structured innovation. The company works alongside WebMD and Medscape to offer up-to-date and reliable data in the healthcare industry.